Generics

Sandoz launches generic Esbriet

The oral medication is used to treat patients with idiopathic pulmonary fibrosis.
Generic firms working on Paxlovid access for low-, middle-income countries

The manufacturers have signed agreements with the Medicines Patent Pool to make and supply the generic version of Pfizer’s oral COVID-19 treatment Paxlovid.
Upsher-Smith makes leadership changes

Taku Nakaoka is now chairman and CEO of Upsher-Smith and Rich Fisher, senior vice president of corporate strategy, is president and COO.
Aurobindo receives FDA OK for generic Sabril

The medication is indicated as adjunctive therapy for adults and pediatric patients aged 2 years old and older with refractory complex partial seizures.
Camber launches generic Reyataz

The medication is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients.
Hikma updates expected launch of authorized generic Xyrem

Hikma now conservatively assumes it will launch its authorized generic on Jan. 1, 2023.
FDA grants Glenmark tentative nod for generic Enstilar

Enstilar foam had a market value of roughly $115.2 million for the 12-month period ending March 2022, according to IQVIA.
FDA gives Lupin clearance for 2 generics

The company received approval for Iloperidone tablets and pregabalin capsules.

FDA grants Sun Pharma approval for generic Pentasa